1. Home
  2. NEON vs PHIO Comparison

NEON vs PHIO Comparison

Compare NEON & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

BUY

Current Price

$0.89

Market Cap

14.8M

Sector

Technology

ML Signal

BUY

Logo Phio Pharmaceuticals Corp.

PHIO

Phio Pharmaceuticals Corp.

HOLD

Current Price

$1.00

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
PHIO
Founded
1997
2003
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
12.9M
IPO Year
1994
2011

Fundamental Metrics

Financial Performance
Metric
NEON
PHIO
Price
$0.89
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.6K
★ 102.7K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.88
N/A
EPS
★ N/A
N/A
Revenue
★ $3,108,000.00
N/A
Revenue This Year
$69.35
N/A
Revenue Next Year
$28.95
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.72
$0.81
52 Week High
$3.81
$4.19

Technical Indicators

Market Signals
Indicator
NEON
PHIO
Relative Strength Index (RSI) 54.53 39.67
Support Level $0.83 $0.98
Resistance Level $0.95 $1.12
Average True Range (ATR) 0.06 0.05
MACD 0.00 -0.00
Stochastic Oscillator 61.40 10.30

Price Performance

Historical Comparison
NEON
PHIO

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.

Share on Social Networks: